| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6B | $13.0B | $12.3B | $18.8B | $16.9B | $4.3B | $3.6B | — |
| Cost of Revenue | $5.8B | $10.1B | $10.4B | $12.9B | $12.4B | $13.0B | $12.8B | — |
| Gross Profit | $1.1B | $2.9B | $1.9B | $5.9B | $4.5B | $1.1B | $0.5B | $1.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.6B | $0.8B | $1.0B | $1.1B | $1.1B | $1.2B | $1.3B | $1.5B |
| Operating Income | $2.3B | $-0.3B | $-1.3B | $2.4B | $1.2B | $0.3B | $-0.4B | $0.8B |
| Net Income | $0.3B | $-0.8B | $-1.7B | $1.5B | $0.8B | $0.1B | $-0.2B | $0.8B |
| EPS (Basic) | $0.78 | $-2.61 | $-5.44 | $4.81 | $2.69 | $0.49 | $-0.67 | $2.53 |
| EPS (Diluted) | $0.75 | $-2.61 | $-5.44 | $4.75 | $2.66 | $0.49 | $-0.67 | $2.46 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.0B | $24.2B | $24.4B | $26.3B | $26.1B | $25.7B | $26.4B | $29.2B |
| Current Assets | $5.9B | $8.1B | $7.9B | $9.5B | $9.8B | $9.0B | $8.5B | $10.6B |
| Cash & Equivalents | $2.1B | $1.9B | $2.0B | $2.3B | $3.4B | $3.0B | $3.5B | $5.0B |
| Total Liabilities | $8.5B | $13.1B | $12.7B | $14.0B | $15.4B | $16.1B | $16.4B | $17.7B |
| Current Liabilities | $5.4B | $6.1B | $5.4B | $5.2B | $4.9B | $4.4B | $3.8B | $4.5B |
| Stockholders' Equity | $5.3B | $10.8B | $10.8B | $12.2B | $10.7B | $9.6B | $10.0B | $11.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.7B | $-0.3B | $-0.4B | $1.9B | $1.9B | $0.8B | $1.5B | $4.2B |
| Investing Cash Flow | $0.1B | $-0.0B | $-0.8B | $-1.2B | $-0.8B | $0.3B | $-1.3B | $-1.7B |
| Capital Expenditures | $0.4B | $0.5B | $0.8B | $1.1B | $1.1B | $0.6B | $0.9B | $0.8B |
| Financing Cash Flow | $-1.6B | $0.2B | $0.9B | $-1.7B | $-0.8B | $-1.5B | $-1.8B | $-3.9B |